Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | PTPRC | P08575 | 1/20 | 0.39 |
| ▸ | PTPRF | P10586 | 1/20 | 0.39 |
| ▸ | CDC25B | P30305 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4561829 | 0.98 | MAOA (0.39) | PTPN1PTPRCPTPRFCDC25BMAOA | |
| SCHEMBL15893576 | 0.69 | PTPN1 (0.36) | PTPN1PTPRCPTPRFCDC25BMAOA | |
| SCHEMBL11678375 | 0.66 | KDM4E (0.38) | PTPN1PTPRCPTPRFCDC25BMAOA | |
| SCHEMBL17969772 | 0.64 | PTPN1 (0.41) | PTPN1PTPRCPTPRFCDC25BMAOA | |
| SCHEMBL10781942 | 0.64 | MAOA (0.64) | PTPN1PTPRCPTPRFCDC25BMAOA | |
| SCHEMBL17969769 | 0.62 | PTPN1 (0.42) | PTPN1PTPRCPTPRFCDC25BMAOA | |
| SCHEMBL30770716 | 0.62 | MAOA (0.50) | PTPN1PTPRCPTPRFCDC25BMAOA | |
| SCHEMBL19386509 | 0.62 | PTPN1 (0.46) | PTPN1PTPRCPTPRFCDC25BMAOA | |
| SCHEMBL30770641 | 0.62 | MAOA (0.50) | PTPN1PTPRCPTPRFCDC25BMAOA | |
| SCHEMBL17969800 | 0.60 | PTPN1 (0.65) | PTPN1PTPRCPTPRFCDC25BMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8247593-B2 | Process for preparing substituted 7-cyano quinone methides | NALCO COMPANY (US) | 2012-08-21 | — | — | US | disclosed |
| WO-2009140145-A1 | PROCESS FOR PREPARING SUBSTITUTED 7-CYANO QUINONE METHIDES | NALCO COMPANY (US) | 2009-11-19 | — | — | WO | disclosed |
| US-20090287013-A1 | PROCESS FOR PREPARING SUBSTITUTED 7-CYANO QUINONE METHIDES | ECOLAB USA INC. | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090287013-A1 | PROCESS FOR PREPARING SUBSTITUTED 7-CYANO QUINONE METHIDES | SQOR, COMT, PAH | PTPN1 895/4885PTPRC 701/4885PTPRF 1320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.